On Jan. 24, Johnson & Johnson (NYSE:JNJ) released fiscal year 2005 earnings for the period ended Dec. 31, 2005.

  • Sales in JNJ's medical devices and diagnostics segment were up 13% for the year.
  • The company's research expense for the year increased by 14.4%.
  • Adjusted net earnings increased by 13.3% in 2005.

(Figures in millions, except per-share data)
Income Statement Highlights

Avg. Est.

FY 2005

FY 2004

% Change






Net Profit










Get back to basics with a look at the income statement.

Margin Checkup

FY 2005

FY 2004


Gross Margin




Op. Margin




Net Margin




Margins are the earnings engine. See how they work.

Balance Sheet Highlights

Inexplicably, the company did not provide balance sheet information in its release.

Related Companies:

  • Procter & Gamble (NYSE:PG)
  • Amgen (NASDAQ:AMGN)
  • Boston Scientific (NYSE:BSX)
  • Allergan (NYSE:AGN)
  • Pfizer (NYSE:PFE)
  • Medtronic (NYSE:MDT)

Related Foolishness:

Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean.

At the time of publication, John Reeves had positions in Johnson & Johnson and Procter & Gamble. Pfizer is a Motley Fool Inside Value selection. Fool rules are here.